|
"Wegovy is definitely not an ideal medication
for achieving your dream goals." "Although Wegovy has enjoyed its fair share of popularity as a weight loss medication for quite few years. However, the latest warnings associated with Wegovy injections has made it an unsafe option to lose weight. Keeping in view the side effects, warnings, and cost, Wegovy is definitely not an ideal medication for achieving your dream goals." (emphasis added) (Outlook Magazine, Wegovy Side Effects: FDA Warns About Safety Risks Of Semaglutide Injection, Aug. 13, 2013).
Contact Nashville Wegovy Lawyer Timothy L. Miles at a Nashville Wegovy law firm today if you suffered Wegovy side effects about a Wegovy lawsuit
introduction to wegovy
Wegovy is in the same class of drugs as Ozempic. However, while both Wegovy and Ozempic contain the same active compound, Wegovy contains a much higher dose of semaglutide, although it is not listed as a controlled substance. Semaglutide is a member of the glucagon-like peptide 1 (GLP-1) receptor agonists group. It imitates the GLP-1 hormone that is secreted in the digestive tract when food is consumed. GLP-1 has the ability to prompt the body to produce more insulin to bring down blood sugar levels. Additionally, higher amounts of GLP-1 can interact with areas of the brain that suppress appetite and result in a feeling of satisfaction.
Wegovy received the U.S. Food and Drug Administration (FDA) approval as a weight loss medication in 2021, the first new weight loss medication to gain approval in several years. The most common side effects of Wegovy include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu, heartburn, and runny nose or sore throat. The FDA has recently revealed that taking Ozempic (which contains less of the active compound semaglutide than Wegovy), a drug for type-2 diabetes management commonly used off-label for weight loss, carries a heightened risk of gallbladder disease, potentially leading to gallbladder removal or other health complications. The manufacturer of Ozempic failed to warn patients and doctors of the potential risk of developing Ozempic Gallbladder disease or other Ozempic stomach side effects such as Ozempic stomach paralysis or Ozempic gastrointestinal side effects. The FDA has received adverse event reports of gastroparesis/stomach paralysis from individuals who took the GLP-1 Receptor Agonists (RA) drugs including Wegovy. CNN recently reported that at least two people, one taking Ozempic and the other taking Wegovy, have experienced more than just minor stomach issues; these individuals have been diagnosed with gastroparesis, or "paralyzed stomachs". Both Wegovy and Ozempic contain the same active compound, but Wegovy contains a much higher dose of semaglutide. Indeed, there has been a steady increase in the number of reports of individuals being rushed to emergency rooms and for extended hospital stays who developed gastroparesis after taking Wegovy. In this comprehensive and authoritative article, we will examine in detail the link between Wegovy and gastroparesis and the resulting legal implications. WHAT IS WEGOVY?
Semaglutide (Wegovy) injections (2.4 mg per week) are recommended for adults who are overweight or obese and have one or more weight-related health conditions (e.g. high blood pressure, type 2 diabetes, or high cholesterol). It received FDA approval as a weight loss medication in 2021, the first new weight loss medication to gain approval since 2014. The most common side effects of Wegovy include nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu, heartburn, and runny nose or sore throat. Additionally, Wegovy presents the same serious weight loss drug side effects including gastrointestinal side effects, a paralyzed stomach, and other weight loss drugs side effects.
WHAT ARE THE WEGOVY SIDE EFFECTS?
According to the company, the most common side effects of Wegovy are nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu, heartburn, and runny nose or sore throat. Other more serious Wegovy side effects include:
WEGOVY AND GASTROPARESIS
Gastroparesis is a condition that affects the normal movement of the muscles in the stomach, causing delayed emptying of the stomach's contents. It can lead to symptoms such as nausea, vomiting, bloating, and abdominal pain. While there are various factors that can contribute to the development of gastroparesis, recent studies have suggested a potential link between the use of Wegovy and gastroparesis and there has been an increase in the number of reports of individuals who developed gastroparesis after taking Wegovy.
While previous studies found a link between diabetics who take Glucagon-like peptide-1 receptor agonists and an increased risk of gastrointestinal side effects, another study examined the risks of people taking GLP-1 agonists strictly for weight loss such as Wegovy. The study found that the use of GLP-1 agonists for weight loss compared with the use of bupropion-naltrexone was associated with an increased risk of pancreatitis, gastroparesis, and bowel obstruction. The study found that, compared to patients on Contrave, patients taking the two GLP-1 agonists, including Wegovy, had a 9.09 times greater risk of pancreatitis, 4.22 times greater risk of bowel obstruction, and a 3.67 times greater risk of gastroparesis, or stomach paralysis. Moreover, CNN recently reported that at least two people taking GLP-1 agonists, one taking Ozempic and the other taking Wegovy, have experienced more than just minor stomach issues; these individuals have been diagnosed with gastroparesis, or "paralyzed stomachs." In addition, Dr. Andrew Boxer, a gastroenterologist at Gastroenterology Associates of New Jersey, is among a number of gastroenterologists who said he is seeing an increased number of patients coming into his practice complaining of side effects from these types of drugs. In an article in Healthline, Dr. Boxer continued stating that "I was seeing a tremendous amount of people coming in just with nausea, vomiting, and feelings of fullness, early satiety, just not feeling well … Universally these patients were on GLP-1’s." Moreover, doctors have stated additional similar cases are coming to light as the popularity of these drugs has soared. The FDA said it has received reports through its adverse events tracking system of people on these drugs experiencing stomach paralysis that sometimes has not resolved by the time it is reported. Additionally, the American Society of Anesthesiologists warned that patients should stop GLP-1 agonists a week before surgery due to the increased risk that individuals will regurgitate food during surgery, even if they have fasted as directed. If someone vomits under anesthesia it can sometimes cause food and acid in the stomach to make their way into the lungs, possibly causing pneumonia and other similar problems after an operation. Dr. Shilpa Mehra Dang, a gastroenterologist at Medical Offices of Manhattan, stated: "It is very important for doctors and nurses to keep an eye on patients who are taking GLP-1 receptor agonist drugs for any signs of stomach problems, such as sickness, vomiting, bloating, and feeling full before they should. These are all symptoms of gastroparesis." (emphasis added). The exact mechanism by which Wegovy and other GLP-1 receptor agonist drugs may contribute to the development of gastroparesis is not yet fully understood. However, it is thought that the medication may affect the nerves and muscles in the stomach, leading to a disruption in gastric motility. This can result in the delayed emptying of food from the stomach, causing the symptoms associated with gastroparesis. It normally takes around six to eight hours for food to pass from the stomach to the small intestine. With gastroparesis, however. the digestion process is extended with the amount of extension differing from person to person. One study which was published in the Lancet Gastroenterology and Hepatology observed how liraglutide affected digestion. The participants in the study took either liraglutide or a placebo for five weeks and then ate a meal containing a radioactive tracer which allowed researchers to see how long the food stayed in their stomachs. For the individuals taking liraglutide, it took 70 minutes for half their food to leave their stomachs. In contrast, it took only four minutes in the control group, an extreme diversity in the slow-down in digestion. Additionally, for some participants taking liraglutide, it took up to two hours and 30 minutes for half the meal to leave their stomachs. It is important to note that not all individuals who take Wegovy will develop gastroparesis. The link between Wegovy and gastroparesis is still being studied, and further research is needed to determine the extent of this association. Additionally, there may be other factors at play that contribute to the development of gastroparesis in individuals who have taken Wegovy such as diabetes mellitus, Parkinson’s disease, following surgery, or with some medications. Notwithstanding, it cannot be seriously debated that there has been a steady increase in the number of individuals who took Wegovy or drugs in the same class and developed gastroparesis. Jaclyn Bjorklund, had been prescribed Ozempic for management of type 2 diabetes for more than a year before she was switched to Mounjaro. Bjorklund claims that her use of both Ozempic and Mounjaro resulted in severe gastrointestinal events, including “severe vomiting, stomach pain, gastrointestinal burning, being hospitalized for stomach issues on several occasions including visits to the emergency room, [and] teeth falling out due to excessive vomiting, requiring additional medications to alleviate her excessive vomiting and throwing up whole food hours after eating.” It is the increase in reported events like this that continues to rise in number that causes concern about the link between Wegovy and gastroparesis. In fact, a steady increase has been reported in the number of individuals having to be rushed to the emergency room and then for extended hospital stays because they took Wegovy or similar drugs in the same class and developed gastroparesis. If you developed gastroparesis after taking Wegovy, it is crucial to consult with your healthcare provider. They can evaluate your symptoms, conduct necessary tests, and provide appropriate treatment options. It may be necessary to adjust your medication regimen or explore alternative treatments for managing weight loss. REPORTING wegovy SIDE EFFECTS
If you have suffered from Wegovy stomach side effects or any other Wegovy side effects, it is crucial to seek medical attention immediately. Additionally, you should consider reporting your side effects to the FDA through the MedWatch Voluntary Reporting Form or by calling 1-800-332-1088. Reporting your Wegovy side effects can contribute to a better understanding of the risks associated with Wegovy.
ELIGIBILITY FOR A wegovy LAWSUIT AND THE ROLE OF A wegovy LAWYER IN NASHVILLE
If you developed gastroparesis after taking Wegovy or have experienced other serious Wegovy side effects, you may be eligible for a Wegovy lawsuit and pursue compensation for your pain, suffering, medical expenses, and lost wages. To determine your eligibility and understand the legal options available to you, it is advisable to consult a reputable Wegovy lawyer in Nashville. A skilled Wegovy lawyer can evaluate your case, gather evidence, and guide you through the legal process.
One name that immediately pops up is nationally known and widely respected Nashville lawyer Timothy L. Miles, who has valuable experience and has received numerous awards, mostly due to his high ethical standards, and hard work ethic, including most recently being named a Top 25 Class action lawyer by the National Trial Lawyers Association, and has maintained an AV rating from Martindale-Hubble since 2014, was named a 2023 Top Rated Litigator and 2023 Top Rated Lawyer by Martindale-Hubble and ALM, and was recently named a 2023 Elite Lawyer of the South by Martindale-Hubble for the fifth year in a row, and was a recipient of Avvo Client's Choice Award in 2021, in 2022 was featured in the Top 100 Lawyers Magazine and received the Lifetime Achievement Award by Premier Lawyers of America (2019-2021). This will most likely be the only call you need to make. (855) 846-6529 or [email protected]. COMPENSATION IN A wegovy LAWSUIT
If your Wegovy lawsuit is successful, you may be entitled to compensatory damages. These damages can include compensation for past and future medical expenses, pain and suffering, emotional distress, lost wages, and a reduction in your ability to earn an income. In some cases, punitive damages may also be awarded to punish the defendant for their actions.
CONTACT NASHVILLE WEGOVY LAWYER TIMOTHY L. MILES TODAY TO SEE IF YOU ARE ELIGIBLE FOR A WEGOVY LAWSUIT IF YOU SUFFERED WEGOVY SIDE EFFECTS
Contact Nashville Wegovy Lawyer Timothy L. Miles today if you developed gastroparesis after taking Wegovy or suffered other serious Wegovy side effects. You may be eligible for a Wegovy lawsuit and possibly be entitled to substantial compensation.
While there is still time to file a lawsuit, be mindful that these cases are time-sensitive, and give us a call today. Nashville Wegovy Lawyer Timothy L. MilesNashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,Class Action: Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more. Please visit our website or call for free anytime. Comments are closed.
|
|
CONTACT
The Law Offices of Timothy L. Miles Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846-6529 Email: [email protected] HOURS OF OPERATION Mon-Fri: 24/7 Sat-Sun: 24/7 |
CONNECt FacebooK
|
